前列腺癌质子束放疗中直肠水凝胶间隔物较直肠球囊固定改善晚期胃肠道毒性
单中心回顾性观察研究比较局限期前列腺癌质子束放疗中直肠球囊固定与水凝胶间隔物的剂量学参数及晚期胃肠道结局。水凝胶间隔物显著改善直肠剂量学并维持良好的靶区覆盖。多变量分析中仅水凝胶间隔物使用(HR 0.145;
核心结论
- 前列腺癌质子束放疗中使用直肠水凝胶间隔物较直肠球囊固定与显著更低的临床相关晚期直肠出血发生率及更小的患者报告肠道生活质量长期下降相关。
- 结果提示水凝胶间隔物可能较直肠球囊固定在质子束放疗中改善直肠保护。
研究设计与样本
- 单中心回顾性观察研究,纳入2013至2018年接受常规分割、剂量递增质子束放疗的局限期临床T1-4前列腺腺癌患者。
- 患者报告胃肠道毒性前瞻性收集,直肠出血发生率从患者记录中回顾性审查。
主要发现
- 直肠水凝胶间隔物显著改善直肠剂量学,同时维持良好的靶区覆盖。
- 单变量分析中,2级及以上直肠出血概率与直肠剂量增加显著相关。
临床怎么用
- 在前列腺癌质子束放疗中,可考虑使用直肠水凝胶间隔物以改善直肠剂量学并降低晚期直肠出血风险。
- 对接受抗凝治疗的患者,应关注晚期直肠出血风险增高。
局限性
- 回顾性观察研究设计,直肠出血发生率通过患者记录回顾性审查获得。
- 单中心研究,样本来自单一机构2013至2018年接受质子束放疗的患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Our purpose was to compare dosimetric parameters and late gastrointestinal outcomes between patients treated with proton beam therapy (PBT) for localized prostate cancer with rectal balloon immobilization versus a hydrogel rectal spacer. METHODS AND MATERIALS: Patients with localized, clinical stage T1-4 prostate adenocarcinoma were treated at a single institution using conventionally fractionated, dose-escalated PBT from 2013 to 2018. Patient-reported gastrointestinal toxicity was prospectively collected, and the incidence of rectal bleeding was retrospectively reviewed from patient records. RESULTS: One hundred ninety-two patients were treated with rectal balloon immobilization, and 75 were treated with a rectal spacer. Rectal hydrogel spacer significantly improved rectal dosimetry while maintaining excellent target coverage. The 2-year actuarial rate of grade 2+ late rectal bleeding was 19% and 3% in the rectal balloon and hydrogel spacer groups, respectively (P = .003). In univariable analysis, the probability of grade 2+ rectal bleeding was significantly correlated with increasing rectal dose. In multivariable analysis, only receipt of spacer hydrogel (hazard ratio, 0.145; P = .010) and anticoagulation use (hazard ratio, 5.019; P < .001) were significantly associated with grade 2+ bleeding. At 2-year follow-up, patient-reported Expanded Prostate Cancer Index Composite bowel quality of life composite scores were less diminished in the hydrogel spacer group (absolute mean difference, 5.5; P = .030). CONCLUSIONS: Use of rectal hydrogel spacer for prostate PBT is associated with a significantly lower incidence of clinically relevant, late rectal bleeding and lower decrement in long-term, patient-reported bowel quality of life compared with rectal balloon immobilization. Our results suggest that hydrogel spacer may improve rectal sparing compared with rectal balloon immobilization during PBT for prostate cancer.
引用
- Dinh TT, Lee HJ, Macomber MW, et al. Rectal Hydrogel Spacer Improves Late Gastrointestinal Toxicity Compared to Rectal Balloon Immobilization After Proton Beam Radiation Therapy for Localized Prostate Cancer: A Retrospective Observational Study. Int J Radiat Oncol Biol Phys. 2020. PMID: 32035187. doi:10.1016/j.ijrobp.2020.01.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。